The Frequency of PD-L1 Marker Expression in ER Positive, PR Positive, HER2 Negative Invasive Breast Carcinomas, and Its Correlation with Clinicopathological Factors Affecting Prognosis
According to the results of this study, there is no relationship between the PD-L1 expression and well-known clinicopathological prognostic factors in ER-positive, PR-positive, and HER2-negative invasive breast carcinomas.
Authors
- Fereshteh Mohammadizadeh (ORCID: https://orcid.org/0000-0001-9771-2669)
- Tahereh Naraki
- Mahboubeh Vafaei
Institutions
- Isfahan University of Medical Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Advanced Biomedical Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.4103/abr.abr_411_23
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00